{
	"anumber": "A43088228",
	"id": "A43088228_0018",
	"page_index": 18,
	"resources": {
		"full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A43088228_0018/full/max/0/default.jpg"
	},
	"fields": {
		"sex": {
			"ms_sex_llm_v1": "female"
		},
		"doctype": {
			"ms_doctype_v1": "form"
		},
		"form_title": {
			"ms_form_title_llm_v1": "LABORATORY REPORT, 0822174"
		},
		"years": {
			"ms_years_nlp_v1": [2023]
		}
	},
	"is_g325a": false,
	"is_cert_naturalization": false,
	"full_text": "OVB Consolidated Medical Bloanalvsls, Inc. Screened by NARA, 8/18/2023 LABORATORY REPORT 3692 Katella Avenue 3 WONG, HING C MD Los Alamitos, CA 9072 (310) 596-4401 (714) 821-0241 709 ST, SUITE 19 LOS ANGELES 90012 RECTOR AND PATHOLOGIST IVAN SERDAR, M.D. 082174 213-628-7958 ENT SEX PATIENT I.D. PHYSICIAN DATE RECEIVED DATE REPORTED AI CHING FONG F 0197-01012 WONG, HING C 01/23/97 01/29/97 CHEMISTRY Creatinine BUN/Creatinine Calclum T. Billrubin Alk. Phos. AST (SGOT) Glucose BUN Phosphorus T. Protein Albumin Globulln A/G Ratio M 0.6-1.1 mg/dl Ratio 8.4-10.2 mg/dl 0.1-1.2 mg/dl Adult 39-117 U/L M s 37 U/L 70-105 mg/dl 6-19 mg/dl 2.7-4.5 mg/dl 6.5-8.3 g/dl 3.9-5.1 g/dl 2.2-4.2 gm/dl 0.8-2.0 F 0.5-0.9 mg/dl 6-25 Child 8.8.10.8 mg/dl Newborn 1.0-12.0 mg/dl Child 117-390 U/L F s 31 U/L 12 0.7 17 9.2 3.5 7.9 4.4 3.5 1.2 0.8 19 129 122 CHEMISTRY ALT (SGPT) CPK Uric Acid Cholesterol HDL LDH GGTP Sodium Potassium Chloride co, M 3.4-7.0 mg/dl Triglyceride LDL M <40 U/L M 26-190 U/L < 200 M 30-70 mg/dl 94-250 U/L 0-57 U/L 133-148 meq/L 3.3-5.3 meq/L 95-110 meq/L 22-28 meq/l 30-190 mg/dl 60-160 mg/dl F s31 U/L F 26-155 U/L F 2.4-5.7 mg/dl mg/dl F 30-90 mg/dl 11 168 144 3.8 101 5.0 142 59 134 221 CHEMISTRY THYROID SEROLOGY HEMATOLOGY Iron SENSITIVE Rheumatold Sed. Rate UIBC TIBC T3U THYROXINE FTI (Calc) TOTAL T3 RPR ANA Screen Platelet Ct. M 45-160 mcg/dl TSH Factor M 0-10 130-375 ug/dl 245-400 ug/dl 23-36% 5-12 pg/dl 1.2-4.3 86-187 ng/dl Non-Reactive F 30-160 mcg/dl 0.46-3.59 mlu/ml Negative Negative F 0-20mm/hr 130-400x10 28 9.9 2.8 239.0 HEMATOLOGY Hgb Hct RBC MCV MCH MCHC WBC Poly Band Lymph Mono Eosin Baso M14-18 gm/dL M42-52 M 4.7-6.1x10 M 80-94 F12-16 F37-47 4.2-5.4x10e F 81-993 27-33pug 33-37% 4.8-10.8x10 42-75% 0-6% 20-51% 0-5% 0-6% 0-2% 46.7 5.13 91 31.6 34.7 9.4 5 1 16.2 76 18 URINALYSIS WBC Sp. Gravity pH Glucose Protein Ketone Occult Blood RBC Color 1.001-1.030 Appearance M 0-5/HPF 5.0-9.0 Negative Negative Negative Negative 0-3/HPF Epithellal Crystal Casts F 0-6/HPF TEST NORMAL ABNORMAL UNITS NORMAL RANGE VLDL 28.4 1 - 40 RISK FACTOR 3.7 Below ave. M=3.43 F=3.27 Ave. Risk M=4.97 F=4.44 Double ave M=9.55 F=7.05 Triple ave M=23.39 F=11. SEROLOGY H. PYLORI AB, IGG 29.0 U/ml 0.0 - 12.5 * Greater than or Equal 20 U/M 1: Positive, Indicated -- present of IgG Specific Antibody to H. Pylori -- -- * Less than or Equal 12.5 U/ml : Negative, Indicated absent of IgG Specific Antibody to H. Pylori * BETWEEN 12.5 - 20. o U/ml : EQUIVOCAL SUGGEST RETEST ON NEW SAMPLE AFTER 2 - 7 WEEKS. LAB COMMENTS DIFFERENTIAL RBC MORPHOLOGY: NORMAL Few platelet aggregates STATE LAW REQUIRES THE VOMENTESTED BE INFORMED AS TO THE RHESUS (Rh) TYPING TEST RESULTS. Cholesterol normal range is recommended by THE NATIONAL CHOLESTEROL EDUCATION OF ADULTS. PAGE NUMBER 1 END OF REPORT"
}
